ARCHIVES

PDQ Evaluation to Cost NCI More Than Reported

This article is from The Cancer Letter archive.

Vol. 16 No. 26 | June 29, 1990

Download PDF Visit The Full Archive

Related Articles

In Brief: Cox Leaving Columbia To Be Physician In Chief At M.D. Anderson; Will Continue to Head RTOG

April 15, 1988

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

ASRO President Tells Colleagues To Take Charge

October 26, 1990

In Brief: David Tweardy named head of internal medicine at MD Anderson

September 19, 2014

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010